Patient Guide: Doravirine (DOR) in Human Immunodeficiency Virus (HIV)-Infected Children Ages 4 Weeks to <12 Years and <45 kg (MK-1439-066)

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 24 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT04375800
Status: 🟢 Enrolling Now
Condition: Acquired Immunodeficiency Syndrome, HIV Infections, Immunologic Deficiency Syndromes
Phase: PHASE2

Where You Can Participate

This study is available at 24 locations across the country.

Top locations include:
  • • Aurora, Colorado
  • • Atlanta, Georgia
  • • Rionegro., Antioquia
  • • And 21 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Doravirine (DOR) in Human Immunodeficiency Virus (HIV)-Infected Children Ages 4 Weeks to <12 Years and <45 kg (MK-1439-066) - Join Clinical Trial NCTNCT04375800

How to Join This Clinical Trial - NCTNCT04375800

Learn how to participate in this PHASE2 trial studying an investigational therapy for Acquired Immunodeficiency Syndrome, HIV Infections, Immunologic Deficiency Syndromes. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Acquired Immunodeficiency Syndrome, HIV Infections, Immunologic Deficiency Syndromes. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Acquired Immunodeficiency Syndrome, HIV Infections, Immunologic Deficiency Syndromes
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT04375800 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 24 locations. Find a study site near you:

Clinical Research Site

Aurora, Colorado 80045 - United States

Status: COMPLETED

Clinical Research Site

Atlanta, Georgia 30322 - United States

Status: RECRUITING

Clinical Research Site

Rionegro., Antioquia 054040 - Colombia

Status: RECRUITING

Clinical Research Site

Barranquilla, Atlantico 08001 - Colombia

Status: RECRUITING

Clinical Research Site

Cali, Valle Del Cauca 760042 - Colombia

Status: RECRUITING

Clinical Research Site

Mexico City, Distrito Federal 06720 - Mexico

Status: ACTIVE_NOT_RECRUITING

Clinical Research Site

Merida, Yucatan 97000 - Mexico

Status: COMPLETED

Clinical Research Site

Mexico City, 04530 - Mexico

Status: COMPLETED

Clinical Research Site

Kemerovo, Kemerovskaya Oblast 650056 - Russian Federation

Status: RECRUITING

Clinical Research Site

Krasnodar, Krasnodarskiy Kray 350015 - Russian Federation

Status: COMPLETED

And 14 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Acquired Immunodeficiency Syndrome, HIV Infections, Immunologic Deficiency Syndromes:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships